XML 27 R17.htm IDEA: XBRL DOCUMENT v3.21.2
NOTE 12 - SEGMENT INFORMATION
6 Months Ended
Oct. 31, 2021
Notes  
NOTE 12 - SEGMENT INFORMATION

NOTE 12 - SEGMENT INFORMATION

 

The following information is presented in accordance with ASC Topic 280, "Segment Reporting", for the three and six months ended October 31, 2021 and 2020; we accounted for two reportable business segments - (1) natural sweetener (stevioside), and (2) corporate and other pharmaceutical. Our reportable segments are strategic business units that offer different products and are managed separately based on the fundamental differences in their operations. Condensed financial information with respect to these reportable business segments for the three and six months ended October 31, 2021 and 2020 is as follows: 

 

 

Three Months Ended October 31,

Six Months Ended October 31,

 

2021

2020

2021

2020

Revenues:

 

 

 

 

Stevioside - third party

$10,001,477 

$3,830,340 

$16,163,155 

$9,020,803 

Stevioside - related party

- 

502,695 

- 

2,254,518 

Total Stevioside

10,001,477 

4,333,035 

16,163,155 

11,275,321 

 

 

 

 

 

Corporate and other – third party

106,647 

100,809 

213,429 

198,201 

Corporate and other – related party

- 

- 

- 

- 

Total Corporate and other

106,647 

100,809 

213,429 

198,201 

Total segment and consolidated revenues

$10,108,124 

$4,433,844 

$16,376,584 

$11,473,522 

Interest expense:

 

 

 

 

Stevioside

$(119,934) 

$(52,018) 

$(190,605) 

$(131,125) 

Corporate and other

 

 

 

 

Total segment and consolidated interest expense

$(119,934) 

$(52,018) 

$(190,605) 

$(131,125) 

Depreciation and amortization:

 

 

 

 

Stevioside

$312,038  

$266,078  

$623,881  

$519,854  

Corporate and other

56,349  

56,042  

112,942  

106,706  

Total segment and consolidated depreciation and amortization

$368,387  

$322,120  

$736,823  

$626,560  

Income (loss) from operations before income taxes:

 

 

 

 

Stevioside

$(1,941,725) 

$(705,674) 

$(2,753,962) 

$(1,769,927) 

Corporate and other

48,952  

47,223  

111,072  

55,649  

Total loss from continuing operations before income taxes

$(1,892,773) 

$(658,451) 

$(2,642,890) 

$(1,714,278) 

 

October 31,
2021

April 30,
2021

Segment property and equipment:

 

 

  Stevioside

$5,663,314 

$7,354,695 

  Corporate and other

2,722,249 

1,862,420 

    Total property and equipment

$8,385,563 

$9,217,115